Abstract
Purpose
The abnormal activation of matrix metalloproteinases (MMPs) during pregnancy might be involved in the pathogenesis of preeclampsia. The aim of present study was to investigate the possible influence of MMP-7 A-181G and its interaction with MMP-9 C- 1562T polymorphism on the risk of preeclampsia and lipid peroxidation level.
Methods
In a case–control study the MMP-7 A-181G and MMP-9 C-1562T polymorphisms were studied in 168 preeclamptic and 154 healthy pregnant women from Western Iran. The MMP-7 and-9 genotypes were detected using polymerase chain reaction–restriction fragment length polymorphism method.
Results
The frequency of MMP-7 G allele in mild- (37.4 %) and severe-preeclampsia (45.6 %) and controls (40.3 %) were not significantly different. In preeclamptic patients in the presence of MMP-7 AG + GG genotype there was a significantly higher concentration of malondialdehyde (MDA) (10.52 ± 4.18 μM, p = 0.017) compared to that in AA genotype carriers (9 ± 2.89 μM). Also, in the presence of both MMP-7 G and MMP-9 T alleles the MDA concentration (11.6 ± 4.9 μM) was significantly higher compared to the concomitant presence of MMP-7 A and MMP-9 C wild alleles (9.2 ± 3.1 μM, p = 0.02). There was an interaction between two alleles of MMP-7 G and MMP-9 T that significantly increased the risk of severe preeclampsia by 1.4-fold (OR = 1.4, 95 % CI = 1.06–1.85, p = 0.016).
Conclusions
The present study indicates lack of a direct influence of MMP-7 A-181G polymorphism on the risk of preeclampsia. However, this polymorphism through elevation of MDA level as a marker of lipid peroxidation and interaction with MMP-9 C-1562T polymorphism might be associated with the risk of severe preeclampsia.
References
Rahimi Z, Aghaei A, Rahimi Z, Vaisi-Raygani A (2013) Endothelial nitric oxide synthase (eNOS) 4a/b and G894T polymorphisms and susceptibility to preeclampsia. J Reprod Infertil 14:184–189
Siddiqui IA, Jaleel A, Tamimi W, Al Kadri HMF (2010) Role of oxidative stress in the pathogenesis of preeclampsia. Arch Gynecol Obstet 282:469–474
Belo L, Gaffney D, Caslake M, Santos-Silva A, Pereira-Leite L, Quintanilha A et al (2004) Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 112:9–15
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli RC, Duarte G et al (2012) Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Exp Mol Pathol 92:217–221
Galewska Z, Romanowicz L, Jaworski S, Bankowski E (2010) Matrix metalloproteinases, MMP-7 and MMP-26, in plasma and serum of control and preeclamptic umbilical cord blood. Eur J Obstet Gynecol Reprod Biol 150:152–156
Javaid MA, Abdallah MN, Ahmed AS, Sheikh Z (2013) Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview. Acta Neurol Belg 113:381–390
Tapia A, Gangi LM, Zegers-Hochschild F, Balmaceda J, Pommer R, Trejo L et al (2008) Differences in the endometrial transcript profile during the receptive period between women who were refractory to implantation and those who achieved pregnancy. Hum Reprod 23:340–351
Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q et al (2008) Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res 68:6453–6459
Maymon E, Romero R, Pacora P, Gervasi MT, Edwin SS, Gomez R et al (2000) Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 182:1545–1553
Qiu W, Zhou G, Zhai Y, Zhang X, Xie W, Zhang H et al (2008) No Association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomark Prev 17:2514–2518
Galewska Z, Romanowicz L, Jaworski S, Bańkowski E (2008) Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia. Clin Chem Lab Med 46:517–522
Erdem M, Harma M, Harma IM, Arikan I, Barut A (2012) Comparative study of oxidative stress in maternal blood with that of cord blood and maternal milk. Arch Gynecol Obstet 285:371–375
Sibai BM (2011) Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol 205:191–198
Agarwal R (2002) Rapid fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B 775:121–126
Rahimi Z, Akramipour R, Nagel RL, Ahmadi AS, Merat A, Bahrehmand F (2006) The beta-globin gene haplotypes associated with Hb D-Los Angeles [beta121(GH4) Glu – > Gln] in Western Iran. Hemoglobin 30:39–44
Jormsjö S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P (2001) Allele specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21:1834–1839
Rahimi Z, Rahimi Z, Shahsavandi MO, Bidoki K, Rezaei M (2013) Matrix metalloproteinase 9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe preeclampsia. Biomark Med 7:93–98
Rahimi Z, Rahimi Z, Aghaei A, Vaisi-Raygani A (2014) AT2R -1332 G: A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9-1562 C: T polymorphisms: risk factors for susceptibility to preeclampsia. Gene 538:176–181
Romao M, Weel IC, Lifshitz SJ, Peracoli MTS, Witkin SS (2014) Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia. Arch Gynecol Obstet 289:575–579
Amir M, Romano S, Goldman S, Shalev E (2009) Plexin-B1, glycodelin and MMP7 expression in the human fallopian tube and in the endometrium. Reprod Biol Endocrinol 7:152
Rahimi Z, Ahmadi R, Vaisi-Raygani A, Rahimi Z, Bahrehmand F, Parsian A (2013) Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress. J Matern Fetal Neonatal Med 26:1590–1594
Sharma D, Singh A, Trivedi SS, Bhattacharjee J (2011) Intergenotypic variation of nitric oxide and inflammatory markers in preeclampsia: a pilot study in a North Indian population. Hum Immunol 72:436–439
Carty DM, Delles C, Dominiczak AF (2008) Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 18:186–194
Wei SQ, Audibert F, Hidiroglou N, Sarafin K, Julien P, Wu Y et al (2012) Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG 119:832–839
Koken T, Gursoy F, Kahraman A (2010) Long-term alcohol consumption increases pro matrix metalloproteinase-9 levels via oxidative stress. J Med Toxicol 6:126–130
Palei AC, Sandrim VC, Duarte G, Cavalli RC, Gerlach RF, Tanus-Santos JE (2010) Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clin Chim Acta 411:874–877
Chamy VM, Lepe J, Cataln L, Retamal D, Escobar J, Madrid EM (2006) Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 39:229–236
Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S (2006) Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynecol Obstet 94:23–27
Rudra CB, Qiu C, David RM, Bralley JL, Walsh SW, Williams MA (2006) A prospective study of early pregnancy plasma malondialdehyde concentration and risk of preeclampsia. Clin Biochem 39:722–726
Siddiqui A, Jaleel A, Al Kadri HM, Akram S, Tamimi W (2013) Biomarkers of oxidative stress in women with preeclampsia. Biomark Med 7:229–234
Llurba E, Gratacós E, Martin-Gallan P, Cabero L, Dominguez C (2004) A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 37:557–570
Patil SB, Kodliwadmath MV, Kodliwadmath M (2009) Lipid peroxidation and antioxidant activity in complicated pregnancies. Clin Exp Obstet Gynecol 36:110–112
Ahmadi R, Rahimi Z, Vaisi-Raygani A, Kiani A, Jalilian N, Rahimi Z (2012) Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein ε2 allele in severe preeclampsia. Hypertens Pregnancy 31:405–418
Acknowledgments
This work was performed in partial fulfillment of the requirements for MD degree of Dr. Leila Kazemian and was financially supported by a grant from Vice Chancellor for Research of Kermanshah University of Medical Sciences, Kermanshah, Iran.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rahimi, Z., Kazemian, L., Malek-Khosravi, S. et al. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia. Arch Gynecol Obstet 291, 45–51 (2015). https://doi.org/10.1007/s00404-014-3376-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3376-4